Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,330 | -16,528 | -7,540 | -5,151 | -2,773 |
| Depreciation Amortization | 129 | 453 | 331 | 211 | 104 |
| Accounts payable and accrued liabilities | -3 | -833 | -998 | -1,084 | -681 |
| Other Working Capital | -388 | -1,459 | -1,880 | -1,904 | -1,302 |
| Other Operating Activity | 2,271 | 6,519 | 1,341 | 1,415 | 810 |
| Operating Cash Flow | $-3,321 | $-11,848 | $-8,746 | $-6,513 | $-3,842 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -69 | -368 | -303 | -151 | -24 |
| Investing Cash Flow | $-69 | $-368 | $-303 | $-151 | $-24 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 57,607 | 57,611 | 38,368 | 38,368 |
| Financing Cash Flow | $N/A | $57,607 | $57,611 | $38,368 | $38,368 |
| Beginning Cash Position | 54,728 | 9,337 | 9,334 | 9,335 | 9,335 |
| End Cash Position | 51,338 | 54,728 | 57,896 | 41,039 | 43,837 |
| Net Cash Flow | $-3,390 | $45,391 | $48,562 | $31,704 | $34,502 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,321 | -11,848 | -8,746 | -6,513 | -3,842 |
| Capital Expenditure | -69 | -368 | -303 | -151 | -24 |
| Free Cash Flow | -3,390 | -12,216 | -9,049 | -6,664 | -3,866 |